Hindié, E., Champion, C., & Morgat, C. (2024). Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. 2024;85:217–226. European urology, 86(1), e19-e20. https://doi.org/10.1016/j.eururo.2024.02.030
Citácia podle Chicago (17th ed.)Hindié, Elif, Christophe Champion, a Clément Morgat. "Re: Renu S. Eapen, James P. Buteau, Price Jackson, Et Al. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. 2024;85:217–226." European Urology 86, no. 1 (2024): e19-e20. https://doi.org/10.1016/j.eururo.2024.02.030.
Citácia podľa MLA (8th ed.)Hindié, Elif, et al. "Re: Renu S. Eapen, James P. Buteau, Price Jackson, Et Al. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. 2024;85:217–226." European Urology, vol. 86, no. 1, 2024, pp. e19-e20, https://doi.org/10.1016/j.eururo.2024.02.030.